The HIV Antiretroviral Drug Efavirenz has LSD-Like Properties

Efavirenz concentrations in CSF exceed IC50 for wild-type HIV

(2010) B. M. Best et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Design, Synthesis, Radiolabeling, and in Vivo Evaluation of Carbon-11 LabeledN-[2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide, a Potential Positron Emission Tomography Tracer for the Dopamine D4Receptors

(2010) Enza Lacivita et al.   JOURNAL OF MEDICINAL CHEMISTRY

Genistein directly inhibits native and recombinant NMDA receptors

(2010) Renqi Huang et al.   NEUROPHARMACOLOGY

Carisoprodol-Mediated Modulation of GABAA Receptors: In Vitro and in Vivo Studies

(2009) L. A. Gonzalez et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

5-HT2A and 5-HT2C Receptors Exert Opposing Effects on Locomotor Activity in Mice

(2009) Adam L Halberstadt et al.   NEUROPSYCHOPHARMACOLOGY

Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats

(2009) Michael B. Gatch et al.   PSYCHOPHARMACOLOGY

Early-onset drug use and risk for drug dependence problems

(2008) Chuan-Yu Chen et al.   ADDICTIVE BEHAVIORS

Efavirenz – Still First-line King?

(2008) Brookie M Best et al.   Expert Opinion on Drug Metabolism & Toxicology

Antiretroviral Treatment of Adult HIV Infection

(2008) Scott M. Hammer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Ligand Selectivity of D2 Dopamine Receptors Is Modulated by Changes in Local Dynamics Produced by Sodium Binding

(2008) S. S. Ericksen et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Identification of a serotonin/glutamate receptor complex implicated in psychosis

(2008) Javier González-Maeso et al.   NATURE

Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines

(2008) J. C. Winter   PSYCHOPHARMACOLOGY

The behavioral pharmacology of hallucinogens

(2007) William E. Fantegrossi et al.   BIOCHEMICAL PHARMACOLOGY